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Abstract: Clear role descriptions promote the quality of interprofessional collaboration. Currently, 
it is unclear to what extent healthcare professionals consider pharmaceutical care (PC) activities to 
be nurses’ responsibility in order to obtain best care quality. This study aimed to create and evaluate 
a framework describing potential nursing tasks in PC and to investigate nurses’ level of responsi-
bility. A framework of PC tasks and contextual factors was developed based on literature review 
and previous DeMoPhaC project results. Tasks and context were cross-sectionally evaluated using 
an online survey in 14 European countries. A total of 923 nurses, 240 physicians and 199 pharmacists 
responded. The majority would consider nurses responsible for tasks within: medication self-man-
agement (86–97%), patient education (85–96%), medication safety (83–95%), monitoring adherence 
(82–97%), care coordination (82–95%), and drug monitoring (78–96%). The most prevalent level of 
responsibility was ‘with shared responsibility’. Prescription management tasks were considered to 
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be nurses’ responsibility by 48–81% of the professionals. All contextual factors were indicated as 
being relevant for nurses’ role in PC by at least 74% of the participants. No task nor contextual factor 
was removed from the framework after evaluation. This framework can be used to enable healthcare 
professionals to openly discuss allocation of specific (shared) responsibilities and tasks. 
Keywords: nursing; medicines management; medicines optimization; patient safety; interprofes-
sional collaboration; nurses’ responsibility; nurses’ tasks 
 
1. Introduction 
Patient safety is an important global health concern. More than twenty years after the 
publication of the Institute of Medicine’s report To Err is Human, serious efforts have been 
undertaken to decrease the number of medication errors [1–6]. In 2017, the World Health 
Organization’s (WHO) third “Global Patient Safety Challenge on Medication Safety” in-
vited WHO Member States to prioritize medication safety at the national level. The Chal-
lenge aimed to make improvements at each stage of the medication process, including 
prescribing, dispensing, administering, monitoring and use. The target was to reduce se-
vere, avoidable harm resulting from errors or unsafe practices due to weaknesses in health 
systems by 50% by 2022. The success of this Challenge will depend on the high prioritiza-
tion of medication safety within healthcare systems globally [7]. 
Several studies corroborated that pharmaceutical care (PC) can have a serious impact 
on medication safety and patient-reported outcomes [8–11]. In the randomized trial of 
Dürr et al. (2021), the intervention group received an intensified clinical pharmacologi-
cal/pharmaceutical care, which included medication management and structured patient 
counseling. Considerable positive effects on the amount of medication errors, patient 
treatment perception, and severe side effects were shown [6]. 
One of the opportunities to improve PC and medication safety is strengthening in-
terprofessional collaboration in PC [12–17]. Research suggests that an interprofessional 
team approach, involving pharmacists, physicians and nurses, has the potential to im-
prove team drug-therapy decision-making, continuity of care and patient safety [18]. A 
review by Donovan et al. (2018) substantiated that a robust body of data supports im-
provement in patient outcomes when care is provided by an interprofessional team [19]. 
This interprofessional team approach can enable nurses to raise concerns with physicians 
and pharmacists, which can contribute to medication error reduction [20,21]. Further-
more, collaboration problems, such as imbalances of authority, professional boundary 
friction and limited understanding of others’ roles and responsibilities threaten patient 
safety [22,23]. If role clarity is missing in a team, then effective interprofessional collabo-
ration cannot be guaranteed [24]. After all, poorly defined roles can lead to conflicts in 
healthcare teams, which negatively effects patient care and patient outcomes [25]. Nowa-
days, a clear role description of all professionals involved in PC is not always available 
[21,26,27]. In particular, nurses’ roles are not always explicit, distinct and clear to other 
professionals, complicating interprofessional collaboration [28–31]. According to the Na-
tional Interprofessional Competency Framework of the Canadian Interprofessional 
Health Collaborative physicians, pharmacists and nurses must understand not only their 
own roles but also those of other practitioners in the team [32]. The need for a transparent 
framework describing nurses’ roles in PC is therefore indispensable and urgently needed. 
The European Commission funded DeMoPhaC project (DEvelopment of a MOdel for 
nurses’ role in interprofessional PHArmaceutical Care in Europe) investigates the role of 
nurses’ in interprofessional PC in 14 European countries. Within this project several large-
scale quantitative and qualitative studies are being undertaken with healthcare profes-
sionals and nursing students. The overall aim of the project is the development of a frame-
work for nurses’ role in interprofessional PC and the development of an assessment to 
evaluate nursing curricula and nursing students’ competences in PC. The project started 
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in December 2017. The first part focused on the current clinical practice of nurses. This 
cross-sectional study showed that monitoring medicines effects, monitoring medicines 
adherence, nurse prescribing and providing patient education are part of the activities of 
nurses in clinical practice. Moreover, healthcare professionals felt that nurse involvement 
should be extended [33]. The second DeMoPhaC study was a qualitative interview study. 
Healthcare professionals confirmed the positive impact on care quality and patient out-
comes when nurses assumed PC responsibilities. The study evidenced the need for a 
unique and consensus-based PC framework across Europe [34]. In the subsequent scoping 
review of international literature related to PC by nurses, an overview was given of the 
variety within nurses’ responsibilities and tasks in PC. Main areas of responsibility were 
management of therapeutic and adverse effects of medication, medication adherence, pa-
tient medication self-management, patient education and information about medication, 
prescribing, medication safety, and (transition of) care coordination. The extensiveness of 
nurses’ activities showed nurses to be key persons in PC for patients [35]. Only domains 
beyond preparation and administration of medication were taken into account. Prepara-
tion and administration of medication are basic and generally known activities being per-
formed by nurses even before Florence Nightingale laid the foundation of professional 
nursing in the 19th century, and hence are not a topic of discussion [36]. 
Because the scoping review showed nurses can be active in several additional PC 
domains beyond those initially investigated in the DeMoPhaC project, it is unclear 
whether healthcare professionals would consider all PC tasks to be nurses’ full responsi-
bility in obtaining best quality of care, or a certain level of supervision by physicians or 
pharmacists would be required. Additionally, the minimum level of nurse education nec-
essary to perform certain PC tasks has not yet been investigated. 
The results of the first three DeMoPhaC studies offer the opportunity to create a 
framework for nurses’ responsibilities and tasks in PC, together with potential barriers or 
enablers of nurses performing these PC activities. After the development of such a frame-
work, the content should be evaluated. Therefore, the aim of this study is to create and 
evaluate a framework describing potential tasks for nurses in PC and to evaluate to what 
extent physicians, pharmacists and nurses from 14 European countries consider PC-re-
lated tasks beyond preparation and administration of medicines to be nurses’ responsibil-
ity in an ideal healthcare situation with best quality of interprofessional care and patient 
outcomes. 
2. Materials and Methods 
2.1. Study Design 
This observational, descriptive research has a quantitative, cross-sectional study de-
sign. The collection of cross-sectional data at a certain point in time allowed us to gather 
a considerable amount of information from a large pool of participants. The study is re-
ported according to the “Strengthening the Reporting of Observational Studies in Epide-
miology” (STROBE) Statement [37] (Supplementary File S1). In an international setting, 
nurses, physicians and pharmacists were invited to complete an online structured ques-
tionnaire on nurses’ tasks within seven pharmaceutical care domains. 
2.2. Participants and Setting 
The study took place in 14 European countries: Belgium, Czech Republic, Germany, 
Greece, Hungary, Italy, Norway, Portugal, Slovakia, Slovenia, Spain, The Netherlands, 
the Republic of North Macedonia, and the United Kingdom (Wales and England). The 
countries were selected in an earlier phase of the overarching DeMoPhaC project of which 
this study is part. 
We included nurses, physicians and pharmacists employed in clinical practice (com-
munity care, residential care, hospital care and mental healthcare), education, research, 
and policy making. Professionals in training and students were excluded. 
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The estimated sample size to obtain a representative framework of nurses’ role in 
Europe was calculated with the single population proportion formula [38]. The final sam-
ple size was 752, assuming a 50% proportion of risk perception (as this would yield the 
maximum sample size), a 5% margin of error, and 1.96 as the standard score value for a 
95% confidence level. 
2.3. Framework and Survey Development 
In this study, PC is defined as the contribution of “Healthcare professionals” to the 
care of individuals in order to optimize medicines use and improve health outcomes. This 
definition is based on a combination of the definition of the Pharmaceutical Care Network 
Europe (PCNE) and the original definition of Hepler and Strand in 1990 [39,40]. The PCNE 
definition limits PC to the contribution of pharmacists. Because of the broadly recognized 
need for interprofessional collaboration in PC, and in line with the original definition of 
Hepler and Strand, the definition used in this study was extended to all healthcare pro-
fessionals [20,33,41,42]. 
The results of the previous quantitative cross-sectional study [33] and the qualitative 
interview study [34] in European nurses, physicians and pharmacists, followed by the 
scoping review [35] of the literature, resulted in an overview of seven PC domains, 26 
tasks for nurses and 20 contextual factors, which were potential barriers or enablers for 
nurses taking up tasks in PC (Table 1). Based on this overview, a framework, called the 
NUPHAC-EU framework (Nurse and Pharmaceutical Care Europe), was created. 
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Table 1. Overview of 26 potential tasks within 7 pharmaceutical care domains, and 20 contextual factors, for nurses in interprofessional pharmaceutical care, extracted from previous 
DeMoPhaC studies [33–35]. Colors indicate whether the task was part of a pharmaceutical care domain (green) or not (red). 
  Domain 1 * Domain 2 * Domain 3 * Domain 4 * Domain 5 * Domain 6 * Domain 7 * 
Task 1 Observation, documentation, registration, reporting               
Task 2 Assessing patients’ competences               
Task 3 Assessing & addressing patient/family needs               
Task 4 Recognising & preventing risks/complications/drug related problems               
Task 5 Identifying, reporting, addressing contra-indications/drug related problems               
Task 6 Follow-up        
Task 7 Evidence-based practice        
Task 8 Decision making        
Task 9 Communication/discussion with patient/family        
Task 10 Detection of non-adherence, drug abuse/misuse               
Task 11 Motivational interviewing               
Task 12 Inter/intraprofessional referrals               
Task 13 Facilitation of medication management               
Task 14 Self-care support & education of patients               
Task 15 Advice (to patient or other healthcare professional)               
Task 16 Determination of type/dosage               
Task 17 Initiation of medication (reactive/proactive)               
Task 18 Adaptation of dose, dose titration               
Task 19 Decision on continuation/cessation of medication               
Task 20 PRN/standing prescription renewal order               
Task 21 Medication reconciliation               
Task 22 Medication review               
Task 23 Intervention in case of emergency               
Task 24 Discharge planning, transition of care planning               
Task 25 
Transitional care communication, inter/intraprofessional collaboration/communication 
including reporting, advising, informing, alerting and discussing 
       
Task 26 Mentoring colleagues        
CONTEXTUAL FACTORS 
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Level of emergency 
Level of nurse education 
Quality of nurse education 
Interprofessional education 
Adequate reimbursement 
Clarity of interprofessional team members’ role 
Availability of interprofessional team members 
Workload/time to care 
Collaborative approach between nurses, pharmacists and physicians 
Adequate nurse to patient ratio 
Shared digital / electronic patient files and records 
Legal framework in a country 
(Self-)confidence in nurses 
Readiness of healthcare professionals and patients 
Healthcare setting 
Ethical context (e.g., norms, values, …) 
Political context 
Epidemiological context (e.g., demographics, patient needs, professional needs, …) 
* Domain 1—Management of therapeutic and adverse effects of medicines; Domain 2—Management of medicines adherence; Domain 3—Management of patient medication self-
management; Domain 4—Management of patient education and information; Domain 5—Prescription management; Domain 6—Medication safety management; Domain 7—(Transition 
of) care coordination. 
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To evaluate the content of this framework, an English-language questionnaire was 
developed by the Belgian researchers in this study (EDB, BVR, TD) and validated (face 
validity) by the consortium of international experts involved in the DeMoPhaC project. 
Consequently, the questionnaire was adjusted until consensus was reached (Supplemen-
tary File S2). 
The survey consisted of three main parts. In the first part eight multiple choice ques-
tions defined demographics, employment and education.  
The second part consisted of seven matrices with questions about the level of respon-
sibility for nurses performing tasks within each of the seven PC domains (respectively 15, 
17, 16, 14, 22, 16 and 16 tasks, Table 1). Respondents were instructed to envision the ideal 
situation to obtain the best quality of interprofessional care and patient outcomes. This 
part of the questionnaire was different for two groups of participants, depending on their 
ability to distinguish between nurse responsibilities based on nurses’ education level. The 
first group confirmed being able to make this distinction. They were asked to indicate for 
each of the four European levels of nurse education (level 5–8) [43] whether each task 
should be a nursing task and, if so, whether this should be under supervision, with shared 
responsibility, or fully autonomous. Respondents unable to distinguish between levels of 
education were asked to indicate the level of responsibility (not allowed, under supervi-
sion, with shared responsibility or fully autonomous) for nurses in general. For ‘Prescrip-
tion management’, two extra questions were presented: (1) the extent to which nurses 
should be allowed to prescribe medicines in order to obtain best quality of care and patient 
outcomes, and (2) the necessary restrictions to optimize nurse prescribing in an ideal in-
terprofessional healthcare situation. For the first extra question respondents were asked 
to consider an ideal situation, which could be different from the current situation. The 
answering options were: no prescribing, dependent prescribing and independent pre-
scribing. Dependent or supplementary prescribers were defined as “prescribers who’s 
prescribing is based on clinical management plans, which are put in place for individual 
patients and relate only to the patient named in the plan. Plans are compiled and signed 
by both the independent medical prescriber (doctor or dentist), and the supplementary 
(non-medical) prescriber. They must be agreed by the patient or carer” [44]. Independent 
prescribers were defined as “practitioners responsible and accountable for the assessment 
of patients with previously undiagnosed or diagnosed conditions and for decisions about 
the clinical management required, including prescribing” [45]. For the second extra ques-
tion, respondents had the possibility of selecting multiple answers from a list of eight pre-
defined restrictions: no restrictions; only a restricted list of medicines; only in a specific 
context, pathology/specialization; only after specific training; only long-term chronic 
medicines; only low risk medicines; prescription-only medicines only; only in emergency; 
and only within an individual patient clinical management plan. Other restrictions could 
be described in a free text field.  
The third part consisted of 20 questions about contextual factors being barriers or 
enablers for nurses’ roles in interprofessional PC. Respondents had to indicate the factors 
of their current healthcare context on a scale from −5 (great barrier), through 0 (no influ-
ence on nurses’ responsibilities or tasks), to +5 (great enabler). 
The questionnaire was translated into all languages of the participating countries by 
the specific co-authors. In two countries (Belgium and Italy) the instrument was pilot 
tested as to its applicability by all three professional groups. 
2.4. Data Collection 
The weblink to the questionnaire was emailed to key stakeholders, professional as-
sociations, healthcare facilities and professional networks of the researchers in all coun-
tries. Nursing faculties as well as interprofessional colleges (Medicine faculties and Phar-
macy faculties) initiated data collection. The weblink was placed on university websites, 
webpages of professional associations and on social media. Each country received 
monthly updates about the number of participants. 
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We aimed to reach a representative sample of nurses, physicians and pharmacists in 
each country. The length of the questionnaire, however, hindered many potential partici-
pants from completing the survey. Moreover, our data collection period (December 2019–
August 2020) coincided with the start of the Covid-19 pandemic, resulting in less accessi-
bility to healthcare professionals to take part. Therefore, in March 2020, after two months 
of data collection, we decided to decrease the number of questions showed to each re-
spondent. Especially the second part of the questionnaire was shown to be too time con-
suming, when all tasks within all PC domains and all levels of nurse education were con-
sidered. Hence, we switched to a shorter survey with all questions of parts 1 and 3, and 
with only four of the seven matrices presented in part 2. For each participant, the online 
survey program made a random selection of four PC domains to be shown. This resulted 
in a significant reduction in the time required to complete all questions, while still allow-
ing each domain to be sufficiently studied. 
2.5. Data Analysis 
Respondents who ended the survey during or immediately after the first part of the 
questionnaire (demographics, employment, education) were excluded from the data anal-
ysis because they did not provide data relevant to the research question. Data were ana-
lyzed using IBM SPSS Statistics v27.0 (IBM Corp., Armonk, NY, United States). A two-
sided level of significance of 0.05 was used. The main outcome variable was the level of 
responsibility in PC tasks (not allowed, under supervision, with shared responsibility or 
fully autonomous) that would be assigned to nurses in an ideal situation with best quality 
of interprofessional care and patient outcomes, from the perspective of physicians, phar-
macists and nurses themselves. Discontinuous data were described using frequency dis-
tributions; continuous data were described using a mean value, a minimum and a maxi-
mum. To evaluate the statistical significance of the differences between the three profes-
sional groups or between the 14 countries, χ2 test for nominal variables, and Kruskal–
Wallis test for ordinal variables were used. Before Kruskal–Wallis tests were executed, a 
power analysis using G*power (Universität Düsselfdorf, Düsseldorf, Germany) was per-
formed to determine the minimum number of cases in each country [46]. According to the 
F-test ANOVA for fixed effects with an a priori medium effect size of 0.25, an alfa of 0.05, 
and a power of 0.8, at least 28 respondents per group were needed. Consequently, if a 
country had less than 28 responses, it was not included in the calculation of the p-value.  
To clearly visualize as much data as possible, two types of matrices were created. In 
the first matrix type, each cell shows: (1) the percentage of respondents thinking a certain 
task could be a nursing task within a certain PC domain and performed by a nurse with a 
certain level of nurse education, and (2) the color of that cell indicating the mode of the 
level of responsibility (red for “not allowed”, orange for “to be performed under supervi-
sion”, yellow for “to be performed with shared responsibility” or green for “to be per-
formed with full autonomy“). In the second matrix type, the same coloring scheme was 
used. Each cell shows the percentage of respondents considering a certain task to be a 
nursing task within a certain country, without distinguishing between the seven PC do-
mains. To achieve this, the PC domains were restructured in two ways: either all seven 
domains were clustered, or a cluster of six PC domains without “prescription manage-
ment” was considered. 
Data analysis on restructured data resulted in apparently increased sample sizes per 
country, yet these numbers did not refer to unique respondents, but to clustered data of 
multiple PC domains per respondent. 
To evaluate which tasks had to be either included or excluded from the final frame-
work, we chose a 60% cut-off. In other words, we considered a PC task to be excluded 
from the framework if indicated as “not allowed for nurses” by at least 40% of the re-
spondents in each country. If a task was evaluated as to be excluded in some, but not all 
countries, it remained in the framework. After all, the performance of each nursing task 
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in clinical practice will have to be considered in combination with all contextual factors, 
including country-specific prerequisites. 
3. Results 
3.1. The NUPHAC-EU Framework for Nurses’ Role in Interprofessional Pharmaceutical Care in 
Europe 
Taking into account the results of a previous quantitative cross-sectional study [33] and 
a qualitative interview study [34] in European nurses, physicians and pharmacists, followed 
by a scoping review of the literature [35], together with the responses in the current cross-
sectional evaluation, we developed a framework for nurses’ role in interprofessional phar-
maceutical care in Europe (Figure 1). The framework consists of several parts. On top of this, 
the patient and their network are presented. Together with the patient, the family and the 
informal caregivers, the interprofessional team, consisting of physicians, nurses, pharma-
cists and other healthcare professionals, communicates and collaborates in order to obtain 
the best quality of care and patient outcomes. In the middle of the framework, seven PC 
domains, beyond medication preparation and administration, and 26 tasks of nurses within 
these domains, are listed. On the bottom, potential levels of autonomy within the PC do-
mains and tasks are shown, ranging from performing tasks under supervision, through 
shared responsibility, to full autonomy, and being responsible for a more or less restricted 
list of medicines. Finally, on the left and right side, twenty contextual factors are defined, 
being potential barriers or enablers of nurses’ tasks in interprofessional PC. 




Figure 1. The NUPHAC-EU framework for Nurses’ role in interprofessional Pharmaceutical Care in Europe. 
3.2. Research Population to Evaluate the NUPHAC-EU Framework 
A total of 1385 respondents participated, of whom 68% were nurses, 17% physicians 
and 15% pharmacists. The majority (86%) of the respondents were employed in seven of 
the 14 countries: Slovakia, Belgium, Italy, Slovenia, Czech Republic, Spain and Greece. 
Mean age was 41 years, and 73% of the population was female. Mean years of work expe-
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rience in healthcare was 18 years, three quarters of the healthcare professionals were em-
ployed in a hospital, and 83% had an active role in clinical practice. More detailed popu-
lation characteristics are presented in Table 2. 
Table 2. Population characteristics (n = 1385). 
 
All  
(n = 1385) 
Nurses 
(n = 923) 
Physicians 
(n = 240) 
Pharmacists 
(n = 199) 
Demographical Data % of Total (n) % % % 








United Kingdom (Wales + England) 



















































































Age (years), mean (min-max) 40.8 (18–71) 40.5 (18–71) 42.9 (25–69) 38.7 (23–68) 
Job Characteristics     
Work experience in HC (years), mean (min-max) 17.5 (0.3–60) 18.0 (0.5–60) 17.1 (0.5–47) 15.7 (0.3–45) 
Work experience in HC (setting) †     
Hospital care 








































Educational Characteristics     













† More than one answer possible. HC = healthcare. EQF = European Qualifications Framework [43]. 
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3.3. Healthcare Professionals’ Opinions about the Level of Nurse Responsibility for Nurses 
Performing Tasks in Interprofessional Pharmaceutical Care 
In the second part of the data collection, the respondents were presented a random 
selection of four out of seven PC domains, resulting in smaller samples for domain-spe-
cific questions. Questions about domains 1 to 7 were answered by respectively 731, 796, 
726, 731, 669, 738, and 711 respondents. 
3.3.1. Levels of Nurse Responsibility for European Nurses 
Looking at healthcare professionals’ opinions without distinguishing between coun-
tries or levels of nurse education, we found that, in an ideal situation, in order to obtain 
best quality of care and patient outcomes, the majority of the respondents would consider 
all but four PC tasks to be nurses’ responsibility. These four non-considered tasks were 
specific for the domain ‘prescription management’: determining type or dosage of medi-
cines, initiating medication, adapting of dose and dose titration and deciding on continu-
ation or cessation of medication. For these tasks, 52.4%, 50.5%, 51.6%, and 51.3% of the 
respondents, respectively, did not consider them to be nurses’ responsibility. Neverthe-
less, almost half of the respondents did consider these tasks as possible nursing tasks; 
hence, all 26 predefined tasks were included into the NUPHAC-EU framework. 
Percentages of respondents not considering PC tasks to be nurses’ responsibility 
ranged from 3.6% to 21.7% for tasks within management of therapeutic and adverse ef-
fects, from 3.0% to 18.2% for tasks within management of medicines adherence, from 3.1% 
to 14.2% for tasks within management of patient medication self-management, from 3.7% 
to 14.9% for tasks within management of patient education and information, from 18.9% 
to 52.4% for tasks within prescription management, from 4.6% to 16.5% for tasks within 
medication safety management, and from 5.2% to 18.0% for tasks within transition of care 
coordination.  
For the majority of the tasks, “shared responsibility” between nurses and other 
healthcare professionals was seen as the most appropriate level of responsibility. Detailed 
percentages of the level of responsibility per task (under supervision, with shared respon-
sibility or fully autonomous) are presented in Figure 2 and Supplementary Table S1. 




Figure 2. Healthcare professionals’ opinions about the level of nurse responsibility in seven pharmaceutical care domains. 
Furthermore, opinions on whether or not nurses should perform PC tasks differed 
significantly between physicians, pharmacists and nurses for almost all tasks (p < 0.001, 
Appendix A Table A1). 
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3.3.2. The Ideal Level of Nurse Prescribing 
More than one-fifth of the nurses considered “independent nurse prescribing” as the 
ideal level of nurse prescribing, compared to only 1% of the physicians and 4% of the 
pharmacists. To obtain best quality of care and patient outcomes, most physicians (55%) 
and pharmacists (58%) believed that nurses should not prescribe, while the majority of 
the nurses (51%) thought ‘dependent prescribing’ would be the ideal level of nurse pre-
scribing (p < 0.001, Table 3). Healthcare professionals’ opinions also differed between 
countries, as shown in Figure 3 (p < 0.001). The country with the most proponents of “no 
nurse prescribing” was Slovakia (63%), whereas in the UK (Wales and England), the most 
“independent nurse” prescribers were considered (41%). 
Table 3. Physicians’ pharmacists’ and nurses’ opinions about the extent to which nurses should be 
allowed to prescribe medicines, in order to obtain best quality of care and patient outcomes (= ideal 
situation, which can be different from the current situation). 







No nurse prescribing 
Dependent nurse prescribing 














p Calculated with Kruskal–Wallis test. 
 
Figure 3. Healthcare providers’ opinion on the level of nurse prescribing authorization in order to obtain best quality of 
care and patient outcomes in 14 countries (n = 913; p < 0.001). 
If nurse prescribing—whether or not (in)dependent—were to be considered, several 
restrictions would be needed in order to optimize prescribing: only after specific training 
(61%), only a restricted list of medicines (54%), only in a specific context or pathology/spe-
cialization (43%), only within an individual patient clinical management plan (36%), only 
low risk medicines (31%), only long-term chronic medicines (30%), only in emergency 
(23%), prescription-only medicines only (19%). Still, 7% of the respondents thought there 
were no restrictions needed. (Table A2, Figure 4) 




Figure 4. Restrictions to optimize nurse prescribing in an ideal interprofessional healthcare situation (n = 537). 
3.3.3. Differences in Levels of Nurse Responsibility between Countries 
Opinions of healthcare professionals about the level of responsibility that nurses 
should have in an ideal situation differed between countries (p < 0.001 for all PC tasks). In 
countries reaching the minimum sample size for all questions, ranges of percentages of 
respondents considering PC tasks to be nursing tasks were 31–96% (Belgium), 52–96% 
(Czech Republic), 63–97% (Greece), 75–99% (Italy), 10–99% (Slovakia), 49–92% (Slovenia), 
and 59–94% (Spain). The lowest percentages were seen for seven tasks (tasks 16-22) that 
were specific to one single responsibility: prescription management (Table 4). All percent-
ages of healthcare professionals considering PC tasks to be nursing tasks were increased 
when ‘prescription management’ was not taken into account (Table A3), indicating lower 
levels of responsibility were assigned to tasks within prescription management. Tasks 
within prescription management were considered to be nurses’ tasks by 31–80% (Bel-
gium), 51–82% (Czech Republic), 63–91% (Greece), 75–93% (Italy), 10–66% (Slovakia), 49–
85% (Slovenia), and 59–90% (Spain) (Table A4).  
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Table 4. Percentages of healthcare professionals considering 26 tasks in seven $ pharmaceutical care domains to be nurses’ tasks in order to obtain best quality of care and patient 
outcomes, split up for 14 countries. 
 
              
p-Value 
 Belgium 
n = 622 * 
Czech Repub-
lic  
n = 199 * 
Germany 
n = 56 * 
Greece 
n = 193 * 
Hungary 
n = 29 * 
Italy 
n = 595 * 
The Nether-
lands 
n = 52 * 
North Macedo-
nia 
n = 52  * 
Norway 
n = 72 * 
Portugal 
n = 80 * 
Slovakia 
n = 603 * 
Slovenia 
n = 350 * 
Spain 
n = 295 * 
Wales + Eng-
land  
n = 118 * 
T1 94.7 91.5 89.9 96.3 74.2 96.3 97.5 87.3 98.4 98.8 73.4 91.8 92.2 94.7 <0.001 
T2 93.8 94.0 86.2 95.9 75.9 96.6 100 86.5 98.4 98.8 76.5 92.0 91.5 92.5 <0.001 
T3 93.4 94.1 90.8 95.2 75.9 98.1 96.9 82.0 100 98.8 93.6 90.9 93.7 93.9 <0.001 
T4 90.0 91.4 94.6 95.9  97.3 98.0 79.3 100 98.6 88.6 90.3 91.8 96.1 <0.001 
T5 82.8 89.2 92.7 95.4  96.2 84.2 70.5 100 98.6 88.7 87.6 89.1 92.2 <0.001 
T6 86.3 90.3 92.1 96.9  94.1 96.4 88.1 100 97.5 96.0 88.0 90.3 94.9 <0.001 
T7 80.7 88.9 87.5 95.0 75.0 95.1 96.2 77.9 94.5 97.4 92.5 86.5 90.3 94.5 <0.001 
T8 66.9 90.9 65.0 86.3  91.4 88.9 60.2 89.1 94.9 81.4 84.5 81.9 88.4 <0.001 
T9 89.1 93.4 85.9 91.9 67.9 96.4 97.0 85.7 100 98.8 93.4 89.1 89.6 97.3 <0.001 
T10 96.1 90.9  97.9  98.5     96.6 89.2 94.1  <0.001 
T11 95.6 94.7 96.6 91.5  97.6 96.8 78.9 100 100 98.6 89.5 91.6 90.7 <0.001 
T12 72.6 87.7 58.5 92.3  94.5 89.8 68.4 90.9 98.8 84.9 86.0 85.2 89.8 <0.001 
T13 74.8 87.1 87.5 91.7  95.8 96.9 79.3 98.3 98.8 62.5 82.7 82.8 80.0 <0.001 
T14 93.1 95.9 98.0 96.6 76.9 97.2 100 93.4 100 100 92.8 88.1 93.2 96.0 <0.001 
T15 83.4 89.4 88.7 95.5 75.0 93.5 98.4 79.5 100 98.7 90.7 85.4 87.2 88.6 <0.001 
T16 30.7 53.3  72.1  78.0     11.1 51.4 65.6  <0.001 
T17 37.7 55.8  68.9  77.1     12.5 51.4 65.1  <0.001 
T18 39.7 52.3  66.7  76.6     11.1 52.1 58.7  <0.001 
T19 39.4 60.5  62.8  75.4     10.2 50.0 66.7  <0.001 
T20 79.0 61.1  76.2  79.8     14.0 49.3 67.7  <0.001 
T21 75.4 75.7  76.2  82.0     21.5 53.4 75.0  <0.001 
T22 56.6 61.5  67.4  77.3     13.3 76.3 82.1  <0.001 
T23 84.4 79.5 71.4 93.0  94.8   77.8 95.2 60.7 86.1 88.9 93.0 <0.001 
T24 81.6 80.0  97.6  94.2     88.3 78.8 82.8  <0.001 
T25 83.9 90.3 88.7 93.4  95.0 98.0 83.9 98.3 100 86.3 87.3 90.2  <0.001 
T26 87.7 88.6 91.4 94.8 75.0 92.6 96.1 80.0 100 98.7 86.9 87.1 87.8 95.1 <0.001 
Source country flags: https://countryflags.com, accessed on 3 May 2021. Overview of tasks (T1. T2. …T26): see Table 1 $ seven domains: (1) Management of therapeutic and adverse 
effects of medicines; (2) Management of medicines adherence; (3) Management of patient medication self-management; (4) Management of patient education and information; (5) 
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Prescription management; (6) Medication safety management; (7) (Transition of) care coordination The colors indicate the level of responsibility that was most prevalent per task (=mode) 
per country: green = full autonomy; yellow = shared responsibility; orange = under supervision; red = not allowed. Blank cells: no percentage presented because of insufficient valid 
responses for this task in this country (n < 28). p calculated with Kruskal–Wallis test for the difference in level of responsibility between countries. Only countries with ≥28 responses 
were taken into account * n = mean number of valid responses. Numbers differ from respondents per country, since tasks were part of several PC domains and are hence shown multiple 
times. 
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In Greece and Italy, all 22 PC tasks were considered to be nurses’ tasks by at least 
60% of the respondents. In the Czech Republic (three tasks), Spain (one task), Belgium 
(five tasks), Slovenia (six tasks) and Slovakia (seven tasks), more than 40% of the respond-
ents did not consider a part of the tasks to be nurses’ tasks in order to obtain best quality 
of care and patient outcomes. The latter tasks were all defined as being part of prescription 
management only (Table 5). Because no one task was indicated as being ‘not allowed for 
nurses’ by at least 40% of the respondents in each country, no tasks were excluded from 
the NUPHAC-EU framework after the evaluation. 
Table 5. Presentation of 26 tasks within seven $ pharmaceutical care domains considered to be nurses’ tasks in order to 
obtain best quality of care and patient outcomes by at least 60% of the respondents, split up for 7 countries. 
        p-Value 
Belgium 
n = 622 * 
Czech Republic 
n = 199 * 
Greece  
n = 193 * 
Italy 
n = 595 * 
Slovakia  
n = 603 * 
Slovenia  
n = 350 * 
Spain  
n = 295 * 
T1 94.7 91.5 96.3 96.3 73.4 91.8 92.2 <0.001 
T2 93.8 94.0 95.9 96.6 76.5 92.0 91.5 <0.001 
T3 93.4 94.1 95.2 98.1 93.6 90.9 93.7 <0.001 
T4 90.0 91.4 95.9 97.3 88.6 90.3 91.8 <0.001 
T5 82.8 89.2 95.4 96.2 88.7 87.6 89.1 <0.001 
T6 86.3 90.3 96.9 94.1 96.0 88.0 90.3 <0.001 
T7 80.7 88.9 95.0 95.1 92.5 86.5 90.3 <0.001 
T8 66.9 90.9 86.3 91.4 81.4 84.5 81.9 <0.001 
T9 89.1 93.4 91.9 96.4 93.4 89.1 89.6 <0.001 
T10 96.1 90.9 97.9 98.5 96.6 89.2 94.1 <0.001 
T11 95.6 94.7 91.5 97.6 98.6 89.5 91.6 <0.001 
T12 72.6 87.7 92.3 94.5 84.9 86.0 85.2 <0.001 
T13 74.8 87.1 91.7 95.8 62.5 82.7 82.8 <0.001 
T14 93.1 95.9 96.6 97.2 92.8 88.1 93.2 <0.001 
T15 83.4 89.4 95.5 93.5 90.7 85.4 87.2 <0.001 
T16 30.7 53.3 72.1 78.0 11.1 51.4 65.6 <0.001 
T17 37.7 55.8 68.9 77.1 12.5 51.4 65.1 <0.001 
T18 39.7 52.3 66.7 76.6 11.1 52.1 58.7 <0.001 
T19 39.4 60.5 62.8 75.4 10.2 50.0 66.7 <0.001 
T20 79.0 61.1 76.2 79.8 14.0 49.3 67.7 <0.001 
T21 75.4 75.7 76.2 82.0 21.5 53.4 75.0 <0.001 
T22 56.6 61.5 67.4 77.3 13.3 76.3 82.1 <0.001 
T23 84.4 79.5 93.0 94.8 60.7 86.1 88.9 <0.001 
T24 81.6 80.0 97.6 94.2 88.3 78.8 82.8 <0.001 
T25 83.9 90.3 93.4 95.0 86.3 87.3 90.2 <0.001 
T26 87.7 88.6 94.8 92.6 86.9 87.1 87.8 <0.001 
Source country flags: https://countryflags.com (accessed on 3 May 2021). Overview of tasks (T1, T2, … T26): see Table 
1. $ seven domains: (1) Management of therapeutic and adverse effects of medicines; (2) Management of medicines adher-
ence; (3) Management of patient medication self-management; (4) Management of patient education and information; (5) 
Prescription management; (6) Medication safety management; (7) (Transition of) care coordination Green cells indicate the 
task was considered to be nurses’ task by ≥60% of the respondents (exact % in the cells); red cells indicate the task was not 
considered to be nurses’ task by >40% of the respondents (exact % in the cells); p calculated with Chi2 tests for the difference 
in opinion (whether or not nurses’ task) between countries. * n = mean number of valid responses. Numbers differ from 
respondents per country since tasks were part of several pharmaceutical care domains and are hence shown multiple 
times. Only countries with ≥28 responses for all 22 tasks were taken into account. 
3.3.4. Levels of Nurse Responsibility for European Nurses of Different Educational Levels 
Slightly more than half of the respondents indicated that they were able to make a 
distinction between nurse responsibilities based on nurses’ educational level (53%), where 
significantly more nurses (62%) were able to distinguish this item compared to physicians 
(35%) and pharmacists (28%) (p < 0.001). 
Within this subsample of healthcare professionals, being able to differentiate be-
tween levels of nurse education, most respondents indicated that all PC tasks within all 
PC domains could be performed by nurses of all educational levels. Between 80% and 
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100% of the respondents considered that PC tasks could be performed by level 5 nurses. 
These percentages increased for level 6 nurses (89–100%), level 7 nurses (96–100%) and 
level 8 nurses (98–100%). 
Most tasks were considered to be able to be performed fully autonomously by level 
8 nurses, and preferably with shared responsibility by level 5, 6, and 7 nurses. Detailed 
percentages of the level of autonomy per task, per PC domain and per level of nurse edu-
cation are presented in Supplementary Table S1 and Table A5. 
3.4. Contextual Factors of Nurses’ Role in Current Interprofessional PC 
Twenty potential barriers or enablers of nurses’ role in interprofessional PC were 
presented to the participants. Factors were rated both as barriers and as enablers, median 
scores ranged from 0 (no influence) to +3 (enabler), and means ranged from −0.2 to +1.9. 
The highest mean scores were seen for “quality of nurse education”, “level of nurse edu-
cation”, “interprofessional education”, and “collaborative approach between nurses, phy-
sicians and pharmacists” (respectively 1.9, 1.8, 1.6, and 1.5). Figure 5 shows all factors were 
indicated as barriers or enablers of nurses’ role by at least three quarters of the respond-
ents. Therefore, none of these predefined factors were removed as contextual factors from 
the NUPHAC-EU framework. 
Two potential influencing factors were investigated in more detail: the country and 
nurses’ educational level. 
 
Figure 5. Bar charts (left side) for the percentage of respondents considering 20 contextual factors as barriers or enablers 
of nurse’ role in interprofessional pharmaceutical care, supplemented with boxplots (right side) for the scores on a 10-
point scale from -5 (great barrier) to +5 (great enabler) (n = 1005). 
4. Discussion 
A framework for nurses’ role aiming for the best quality of interprofessional PC and 
patient outcomes in an ideal healthcare situation was developed. This NUPHAC-EU 
framework consists of the patient and their personal and professional network, seven PC 
domains, and 26 tasks within these domains. These tasks could be performed by nurses 
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with varying levels of autonomy, depending on a range of contextual factors. The majority 
of the healthcare professionals would consider nurses responsible for tasks within six of 
the seven domains proposed. Within the domain of prescription management, more re-
spondents were reluctant to allow nurses to take up responsibilities. Overall, physicians, 
pharmacists and nurses considered a shared responsibility level to be the most appropri-
ate level of autonomy for nurses in PC. 
When interpreting the results of this study, it is of major importance to recognize that 
more than half of the participants were nurses. The comparisons between professional 
groups showed nurses entrusted with higher levels of responsibility to perform PC tasks. 
This might have distorted our results in favor of nurses’ more positive opinions regarding 
their own roles and their opinion about the most appropriate level of autonomy in PC. 
Despite the higher representation of nurses in this sample, we are convinced of the great 
value of the NUPHAC-EU framework, which aimed to offer healthcare professionals a 
discussion tool in a wide range of interprofessional PC situations. The level of nurse re-
sponsibility for a certain task in a certain healthcare situation can be different between and 
within countries, depending on the contextual factors. Because of this, no tasks were re-
moved from the framework, even though they were considered to be irrelevant by the 
majority of professionals in one or more countries. After all, in other countries with other 
contexts, the same tasks did meet all prerequisites to be allowed for nurses. This under-
lines the importance of interpreting the framework as a whole, when openly discussing 
the allocation of specific (shared) responsibilities and tasks. 
Most of the comparisons between the opinions of pharmacists, physicians and nurses 
showed fewer pharmacists would consider nurses taking up responsibilities in PC. This 
was also seen in the EUPRON study, where the perceived quality of nurses’ competences 
in PC was rated the lowest by pharmacists, and hence they were less convinced of the 
positive impact of nurse involvement on PC [33]. Compared to daily collaborations be-
tween physicians and nurses, contacts between pharmacists and nurses in healthcare set-
tings are less frequent or even rare [47–49]. This lack of familiarity between pharmacists 
and nurses might explain the higher percentages of pharmacists considering PC tasks not 
to be suitable for nurses. After all, it is more difficult to understand another professional’s 
role, when not working directly together with them. Additionally, the fact that PC was 
described by pharmacists as a pharmacist-only responsibility for decades may have neg-
atively influenced pharmacists’ opinions in this study, explicitly defining the role of 
nurses in PC [8,9]. It should be stressed that the development of a model for nurses’ role 
in PC is in no way an intention to take away responsibilities from other professional 
groups. In contrast, the NUPHAC-EU model is meant to enable interprofessional 
collaboration by means of greater role transparancy, which has been demonstrated to 
positively effect care quality and patient outcomes [50–55]. 
Aiken et al. (2003) showed that educational differences in nurses are related to patient 
outcomes. Surgical patients experienced lower mortality and failure-to-rescue rates in 
hospitals with higher proportions of nurses educated at the baccalaureate level (= level 6 
of EQF) or higher. They suggested that recruiting and retaining bachelor degree nurses 
could lead to substantial improvements in quality of care [56]. These results can be ex-
tended to the opinions about nurses’ responsibilities in our sample of healthcare profes-
sionals. As the level of nurse education increased, more professionals considered PC tasks 
to be nursing tasks with higher levels of autonomy. Our results, however, cannot be gen-
eralized to the opinions of all professional groups, since fewer physicians and pharmacists 
were able to make a distinction between responsibilities based on nurse educational lev-
els. As already discussed, this might have biased our results. 
For tasks within prescription management, more hesitancy regarding nurse involve-
ment was seen. This is not a surprising result, given these nursing tasks were traditionally 
associated with the medical profession only [57]. However, this situation has been chang-
ing in recent decades, with an increasing number of countries legally allowing nurses to 
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prescribe certain medications, either dependently or independently [58]. Despite this rel-
atively recent task shifting between physicians and nurses, studies showed the benefits of 
nurses taking part in prescription management. Nurse prescribing can improve patient 
outcomes, such as blood pressure [59,60], cholesterol levels [61], HbA1C levels [60,62], 
medication adherence [63,64], and patients’ quality of life [65]. Nurse prescribing can also 
enhance patient safety and satisfaction [62,63], and improve care continuity [63]. Next to 
better patient outcomes, increased job satisfaction for nurses [64,66] and higher cost-effec-
tiveness of healthcare services because of reduced inappropriate service use [66,67] are 
also linked to nurse prescribing. We therefore call for a more accepting attitude from 
healthcare professionals towards nurses prescribing medicines within certain boundaries. 
4.1. Implications for Clinical Practice, Research, Education, and Policy 
Nurses, as key personnel in healthcare delivery, play a critical role in patient care, 
and more specifically, in PC. To establish appropriate interprofessional relationships, it is 
necessary to provide a framework that allows the building of trust, co-operation and com-
munication [68]. Our NUPHAC-EU framework will increase the awareness of nurses’ (po-
tential) roles, which will allow pharmacists, nurses and physicians to benefit from team-
work [18]. In further research, expert consensus should be sought regarding necessary PC 
knowledge, skills, and attitudes for nurses. An overview of nurse competencies based on 
the NUPHAC-EU framework will enable the development of an assessment to evaluate 
nurse competences in PC, as guidance for evaluating nurse education, and as a tool for 
nurse educators. The assessment could also be a tool in the strategy of lifelong learning 
among nurses in clinical practice. 
Currently, the training of healthcare professionals remains largely a single discipline, 
which may reduce the ability to collaborate interprofessionally [69]. Therefore, more in-
terprofessional education should be organized, as well as rigorous research on interpro-
fessional PC to tackle the remaining barriers. The enablers and barriers presented in the 
NUPHAC-EU framework can help policy makers and nurse managers to gain insights 
into the prerequisites for nurses’ role in PC. This can support them in developing work-
force planning policies and creating adapted contexts for more barrier-free nurse labor 
mobility, taking into account feasibility, cost-effectiveness, care quality and patient out-
comes. After all, the international mobility of nurses is an increasing phenomenon in the 
EU, as well as worldwide, and several advantages have been described: a balanced supply 
and demand for the health workforce; foreign-trained health professionals can fill service 
gaps and nurse shortages; increased cultural diversity; decreased average age to keep sal-
ary levels in check; and sending remittances to the less wealthy home countries [70,71]. 
4.2. Strengths and Limitations of the Study 
This study has significant strengths. The NUPHAC-EU framework was developed 
based on the results of two large-scale quantitative and qualitative studies and a scoping 
review of the literature, followed by a stakeholders’ evaluation. This resulted in a frame-
work adapted to the needs of clinical practice, with insights into the preferences of the 
interprofessional team in which nurses collaborate on a daily basis. The framework offers 
opportunities for discussion in clinical practice, collaboration in research, nurse education 
and labor mobility of nurses and nursing students. To our knowledge, never before have 
nurses’ responsibilities in 26 PC-related tasks been distinguished between four EQF levels. 
Despite the limited number of participants at the national level in some countries, the 
overall sample size was satisfactory and provided interesting insights into the extent to 
which European healthcare professionals consider PC-related tasks to be nurses’ respon-
sibility in an ideal healthcare situation with the best quality of interprofessional care and 
patient outcomes. 
This internet survey had limitations. The inclusion or exclusion of countries and re-
spondents was determined by whether they were included in the overarching Erasmus + 
project. Additionally, this self-selected sample with an unknown response rate might have 
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led to a distortion of the results due to only the most motivated professionals participat-
ing. The enormous workload of healthcare professionals at the time of the COVID-19 pan-
demic forced many clinicians to neglect activities such as completing scientific surveys. 
The sample also favored more educated, computer-literate professionals, because of the 
Internet recruitment. In seven counties, i.e., Germany, Hungary, The Netherlands, the Re-
public of North Macedonia, Norway, Portugal and the UK, there were low response rates. 
Therefore, our findings may not be as applicable in these parts of Europe. Finally, as with 
all self-reports, we cannot discount acquiescence response bias [72]. The views of 1385 
professionals are important, yet we have to assume that some might have been biased by 
socially desirable responding. 
5. Conclusions 
This study aimed to evaluate to what extent physicians, pharmacists and nurses from 
14 European countries considered PC-related tasks beyond preparation and administra-
tion of medicines to be nurses’ responsibility in an ideal healthcare situation with the best 
quality of interprofessional care and patient outcomes. The developed NUPHAC-EU 
framework consisted of the patient and their personal and professional network, seven 
PC domains, and 26 tasks within these domains, which could be performed by nurses 
with varying levels of autonomy, depending on a range of contextual factors. The majority 
of healthcare professionals would consider nurses to be responsible for tasks within six of 
the seven domains proposed. Within the domain of prescription management, more re-
spondents were reluctant to allow nurses to take up responsibilities. Overall, physicians, 
pharmacists and nurses considered a shared responsibility level as the most appropriate 
level of autonomy for nurses in PC. 
This framework enables healthcare professionals to openly discuss allocation of spe-
cific (shared) responsibilities and tasks. 
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Table A1. Percentages of physicians, pharmacists and nurses considering 26 tasks in seven pharmaceutical care domains as nurses’ tasks in order to obtain best quality of 
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1 98.0 95.8 89.8 * 96.3 97.2 92.5  97.3 100 85.7 * 97.5 97.2 85.6 * 77.1 55.3 48.4 * 96.9 67.8 87.7 * 95.4 68.8 87.0 * 
2 95.5 95.6 91.2  95.4 97.7 94.2  98.0 98.6 89.1 * 97.0 97.2 83.7 * 80.3 55.6 47.8 * 97.2 65.1 85.7 * 95.7 68.1 87.5 * 
3 96.3 98.5 90.2 * 97.5 97.8 93.1 * 97.6 99.3 90.5 * 97.2 97.9 89.6 * 82.1 86.4 68.9 * 96.8 95.1 88.6 * 95.9 95.7 88.7 * 
4 96.9 93.9 85.7 * 96.8 98.5 81.5 * 97.4 97.1 85.4 *     80.8 86.6 53.1 * 96.7 93.8 81.6 * 96.0 92.1 81.2 * 
5 91.3 91.0 79.1 * 93.7 91.8 78.4 * 94.8 96.3 77.7 *     80.0 85.3 60.0 * 95.0 92.1 78.6 * 92.9 93.9 77.2 * 
6 94.1 93.9 83.9 * 95.2 97.1 85.0 * 96.1 96.5 82.9 * 95.0 97.2 86.8 * 78.9 88.5 69.4 * 96.2 91.7 85.8 * 94.5 93.6 82.5 * 
7 94.9 87.6 82.0 * 94.3 92.1 81.5 * 93.9 94.0 83.2 * 94.3 93.9 79.8 * 76.3 83.6 54.5 * 94.2 89.9 77.1 * 93.9 89.1 83.8 * 
8 84.7 79.1 73.9 * 88.0 83.8 70.5 * 88.4 85.5 73.5 * 90.1 87.9 71.4 * 67.3 75.2 36.7 * 87.5 81.9 65.3 * 86.3 80.9 71.6 * 
9 94.0 91.3 86.1 * 95.3 95.5 86.9 * 96.3 97.2 85.0 * 95.5 97.9 83.7 * 79.7 90.6 66.3 * 95.2 95.0 89.4  95.3 92.1 85.6 * 
10     96.6 98.5 85.3 *                     
11     96.8 96.2 89.8 * 95.2 96.5 88.3 * 95.3 97.9 82.5 *             
12 87.2 84.4 80.4  90.3 88.7 78.7 * 88.9 91.2 80.2 * 89.7 87.5 72.5 * 71.5 80.2 50 * 88.8 86.8 77.6 * 88.6 85.6 77.1 * 
13 85.4 64.9 63.2 * 88.9 63.6 68.5 * 88.1 92.0 72.0 * 88.6 88.8 63.4 * 69.1 81.4 47.9 * 88.9 85.6 62.5 * 89.2 65.9 71.8 * 
14 96.3 69.5 80.0 * 97.5 96.2 88.1 * 97.0 97.1 84.3 * 97.8 97.2 82.7 *     96.4 93.0 85.6 * 95.6 93.3 85.4 * 
15 93.6 89.2 82.5 * 95.2 92.5 82.7 * 93.4 90.4 80.8 * 94.1 92.1 81.0 * 73.9 82.5 50.5 * 93.1 92.2 81.4 * 93.2 84.0 82.0 * 
16                 53.8 40.6 26.9 *         
17                 57.1 38.1 27.7 *         
18                 55.2 39.0 28.1 *         
19                 57.0 35.2 26.9 *         
20                 64.8 54.0 43.0 *         
21                 68.5 59.4 38.3 *         
22                 66.0 49.2 43.7 *         
23                 77.8 65.2 45.7 * 94.8 94.6 85.4 *     
24                         88.4 90.2 76.0 * 
25 90.6 90.2 84.7 * 94.2 92.4 86.5 * 94.3 92.2 86.4 * 92.9 94.2 79.8 * 78.6 68.2 55.4 * 92.8 93.5 85.7 * 91.8 93.3 84.7 * 
26 95.3 86.6 86.8 * 93.8 93.8 85.1 * 92.3 97.7 82.8 * 94.3 95.6 83 * 75.9 66.7 53.7 * 92.3 94.3 85.6 * 92.7 93.2 84.8 * 
Overview of tasks 1–26: see Table 1; The colors indicate the level of responsibility that was most prevalent for each task per professional group (= mode): green = full 
autonomy; yellow = shared responsibility; orange = under supervision; red = not allowed; (*) if p < 0.05. p-value calculated with chi squared tests for the difference in 
opinion (to be performed by nurses or not) between nurses, pharmacists and physicians. 
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Chi2 tests were used to calculate p-values for the difference in opinion between physicians, pharmacists & nurses. Bold numbers indicate p < 0.05. 
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Table A3. Percentages of healthcare professionals considering 19 tasks within six$ pharmaceutical care domains as nurses’ tasks in order to obtain best quality of care and 
patient outcomes, split up for 14 countries. 
 
              
p-Value 
Belgium  
n = 710 * 
Czech 
Republic  
n = 233 * 
Germany 
n = 48 * 
Greece  
n = 218 * 
Hungary  
n = 24 * 
Italy  
n = 676 * 
The Nether-
lands  




n = 75 * 
Norway  
n = 50 * 
Portugal  
n = 64 * 
Slovakia  
n = 691 * 
Slovenia  
n = 400 * 
Spain  
n = 337 * 
Wales + 
England 
n = 107 * 
T1 97.4 93.3 94.6 98.6 75.9 98.1 98.7 88.0 100 100 83.4 93.3 93.9 93.9 <0.001 
T2 95.9 95.4 88.7 97.4 77.8 98.1 100 87.7 100 100 85.4 93.3 93.0 92.1 <0.001 
T3 95.5 95.8 94.4 96.6 77.8 98.9 96.8 87.3 100 100 97.9 92.2 94.4 94.5 <0.001 
T4 92.5 94.1 97.7 97.3 78.3 98.4 100 82.6 100 100 94.5 91.9 93.4 96.3 <0.001 
T5 85.0 92.0 95.3 96.8 77.3 97.1 86.1 70.5 100 100 93.1 88.8 90.8 91.6 <0.001 
T6 88.8 92.2 98.0 98.2 76.0 95.2 98.1 90.8 100 100 99.0 88.8 92.0 94.9 <0.001 
T7 83.6 92.0 93.5 96.1 76.9 96.0 98.0 80.3 93.8 100 96.8 87.8 91.6 95.2 <0.001 
T8 69.9 93.8 71.4 88.2 73.1 92.6 90.4 64.9 97.1 97.0 86.7 85.5 84.0 88.2 <0.001 
T9 90.8 95.9 90.6 93.1 69.2 97.3 98.4 87.2 100 100 97.5 90.1 90.2 97.6 <0.001 
T10 96.1 90.9  97.9  98.5     96.6 89.2 94.1  <0.001 
T11 95.6 94.7 96.6 91.5  97.6 96.8 78.9 100 100 98.6 89.5 91.6 90.7 <0.001 
T12 74.8 90.1 63.6 93.5 70.8 95.7 89.4 72.2 91.9 100 90.4 86.8 85.7 89.0 <0.001 
T13 77.1 90.4 90.4 92.6 69.6 96.9 96.7 82.4 100 100 65.5 84.2 84.6 80.0 <0.001 
T14 93.1 95.9 98.0 96.6 76.9 97.2 100 93.4 100 100 92.8 88.1 93.2 96.0 <0.001 
T15 85.4 92.2 94.0 96.6 76.9 94.7 100 83.6 100 100 96.8 96.0 90.1 87.1 <0.001 
T23 90.2 88.4  97.6  97.1     97.9 90.0 95.7  <0.001 
T24 81.6 80.0  97.6  94.2     88.3 78.8 82.8  <0.001 
T25 85.5 91.9 94.0 93.8 75.0 95.6 100 87.2 98.1 100 94.7 87.7 90.9 94.8 <0.001 
T26 89.6 92.3 95.8 95.6 76.0 93.8 100 84.8 100 100 95.3 87.9 89.0 95.0 <0.001 
Source country flags: https://countryflags.com accessed on 3 May 2021. Overview of tasks (T1, T2,…T26): see Table 1. $ six domains: (1) Management of therapeutic and 
adverse effects of medicines; (2) Management of medicines adherence; (3) Management of patient medication self-management; (4) Management of patient education and 
information; (5) Medication safety management; (6) (Transition of) care coordination. The colors indicate the level of responsibility that was most prevalent for each task 
per country (= mode): green = full autonomy; yellow = shared responsibility; orange = under supervision; red = not allowed. Blank cells: no percentage presented because 
of insufficient valid responses for this task in this country (n < 28). p-Value calculated with Kruskal-Wallis test for the difference in level of responsibility between countries. 
Only countries with ≥28 responses were taken into account. * n = mean number of valid responses. Numbers differ from respondents per country since tasks were part of 
several PC domains and hence shown multiple times. 
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Table A4. Percentages of healthcare professionals considering 22 tasks within prescription management as nurses’ tasks in 
order to obtain best quality of care and patient outcomes, split up for seven countries 
 
       
p-Value 
 Belgium 
n = 134 
Czech  
Republic  
n = 38 
Greece 
n = 43 
Italy 
n = 130 
Slovakia 
n = 127 
Slovenia 
n = 74 
Spain 
n = 64 
T1 76.3 77.5 81.8 85.1 15.4 81.6 81.8 <0.001 
T2 79.5 81.8 86.4 87.8 17.3 83.3 82.4 <0.001 
T3 79.4 80.0 86.0 93.0 64.8 82.2 89.4 <0.001 
T4 76.1 74.4 88.4 91.5 56.2 81.6 83.3 <0.001 
T5 71.5 71.8 88.4 91.5 64.6 81.6 80.3 <0.001 
T6 70.1 76.3 88.6 87.7 71.4 75.8 80.3 <0.001 
T7 62.1 66.7 87.8 89.2 63.5 78.4 82.0 <0.001 
T8 47.6 68.6 75.0 84.1 46.0 78.4 68.8 <0.001 
T9 77.8 74.4 84.4 90.7 65.9 82.4 85.7 <0.001 
T12 57.9 67.6 85.4 86.6 48.0 80.8 82.0 <0.001 
T13 60.0 66.7 86.0 89.3 42.6 73.3 71.0 <0.001 
T15 70.7 69.2 88.9 86.0 50.0 81.3 67.7 <0.001 
T16 30.7 53.3 72.1 78.0 11.1 51.4 65.6 <0.001 
117 37.7 55.8 68.9 77.1 12.5 51.4 65.1 <0.001 
T18 39.7 52.3 66.7 76.6 11.1 52.1 58.7 <0.001 
T19 39.4 60.5 62.8 75.4 10.2 50.0 66.7 <0.001 
T20 79.0 61.1 76.2 79.8 14.0 49.3 67.7 <0.001 
T21 75.4 75.7 76.2 82.0 21.5 53.4 75.0 <0.001 
T22 56.6 61.5 67.4 77.3 13.3 76.3 82.1 <0.001 
T23 78.2 70.0 88.6 92.2 18.4 81.6 81.5 <0.001 
T25 73.2 77.8 90.7 91.4 31.8 84.9 85.7 <0.001 
T26 75.4 66.7 90.2 85.2 33.6 81.7 80.6 <0.001 
Source country flags: https://countryflags.com accessed on 3 May 2021. Overview of tasks (T1, T2,…T26): see Table 1. The 
colors indicate the level of responsibility that was most prevalent for each task per country (= mode): green = full auton-
omy; yellow = shared responsibility; orange = under supervision; red = not allowed. p-Value calculated with Kruskal-
Wallis test for the difference in level of responsibility between countries. Only 7 countries with ≥28 responses were taken 
into account. 
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Table A5. Percentages of healthcare professionals considering 26 tasks in seven pharmaceutical care domains as nursing tasks in order to perform best quality of care and patient 
outcomes, distinguished between level 5-6-7-8 * nurses. 
 Management of 
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(n = 336) 
Management of 
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1 98.6 99.7 100 100 99.7 100 99.7 100 99.7 100 99.7 100 98.9 100 100 100 95.0 98.6 99.3 99.6 99.2 99.7 100 100 99.1 99.4 100 99.7 
2 99.1 100 100 100 99.2 100 99.7 100 99.4 100 99.7 100 99.4 100 100 100 96.0 98.2 99.6 99.6 99.4 100 100 100 99.7 99.1 99.7 99.4 
3 98.9 100 100 100 98.6 100 99.7 100 99.2 100 99.7 100 99.4 100 100 100 97.5 97.9 99.6 99.6 99.7 100 100 100 99.7 99.1 99.7 99.4 
4 98.0 100 100 100 98.4 99.7 99.5 99.7 98.9 99.7 99.4 100     95.8 97.9 100 100 98.9 99.5 99.4 99.7 98.1 99.4 99.7 99.4 
5 97.3 99.1 100 100 96.2 99.2 99.4 99.7 98.2 100 99.4 99.7     96.0 97.9 99.6 100 98.5 99.1 99.7 99.7 98.1 99.1 99.7 99.3 
6 97.9 99.4 99.7 100 97.8 99.2 99.7 100 97.4 99.7 99.4 99.7 97.9 100 100 100 96.0 98.6 100 100 98.6 99.7 100 100 98.1 99.4 100 99.7 
7 94.7 97.9 99.4 100 96.4 98.0 99.7 100 96.9 99.1 99.7 100 95.9 99.4 100 100 93.6 97.7 100 100 96.6 98.8 100 100 97.0 98.4 99.3 99.0 
8 95.7 99.4 99.7 99.7 93.1 97.0 98.2 99.4 97.7 99.0 99.7 100 96.7 100 100 100 90.0 96.6 99.2 99.6 96.3 98.7 98.7 99.3 95.4 97.2 99.3 98.9 
9 98.0 100 100 100 98.1 100 99.7 100 99.2 100 99.4 100 99.1 100 100 100 95.4 98.6 100 100 98.8 100 100 100 98.8 99.7 100 99.7 
10     98.4 100 99.7 100                     
11     97.5 99.7 99.7 100 98.8 99.4 99.4 99.7 98.5 99.7 100 100             
12 95.5 97.2 99.4 100 93.5 98.8 99.7 100 96.7 98.4 99.0 100 95.9 99.3 100 100 93.1 95.9 99.6 100 96.0 99.3 100 100 95.2 98.0 99.0 99.3 
13 95.3 98.2 100 100 97.0 98.5 99.4 99.7 97.3 99.0 99.7 100 97.6 98.7 99.7 99.7 93.7 98.1 99.6 100 96.5 99.4 100 100 96.2 99.0 99.7 99.3 
14 98.5 99.7 100 100 97.8 99.5 99.7 100 98.6 99.7 99.7 100 98.9 99.4 100 100     98.0 99.4 100 100 98.8 98.8 100 99.7 
15 95.6 98.8 99.7 99.7 96.5 99.2 99.4 100 98.7 99.7 99.7 100 96.6 99.7 100 100 91.4 96.6 100 100 98.2 100 100 100 93.2 84.0 82.0 99.3 
16                 83.3 90.2 96.4 98.9         
17                 82.1 91.3 96.1 98.0         
18                 80.2 89.1 96.0 97.5         
19                 84.4 90.1 97.0 98.5         
20                 89.3  99.1 98.7         
21                 91.4 95.8 99.2 99.1         
22                 89.2 93.6 98.3 98.7         
23                 93.6 97.2 100 99.6 96.8 99.4 100 100     
24                         94.1 97.3 99.0 99.0 
25 95.4 99.4 100 100 97.1 99.1 99.7 100 98.2 99.7 99.7 100 97.8 99.7 100 100 94.7 97.0 100 100 97.8 99.7 99.6 99.7 96.1 99.0 100 99.7 
26 93.3 98.2 99.7 100 94.2 98.8 99.4 100 95.9 99.4 99.4 99.7 95.2 99.4 100 100 91.7 95.4 99.6 100 96.3 99.1 99.7 99.7 95.3 98.7 100 99.7 
Overview of tasks 1-26: see Table 1. * Level 5-6-7-8 nurses: level of education according to the European Qualifications Framework (EQF) [43]. The colors indicate the level of responsi-
bility that was most prevalent for each task per level of nurse education and per PC domain (= mode): green = full autonomy; yellow = shared responsibility; orange = under supervision. 
Blank cells indicate the task was not presented to the participants. 
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